Business Description
Bio-Gene Technology Ltd
ISIN : AU000000BGT8
Share Class Description:
ASX:BGT: Ordinary SharesDescription
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group's product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.88 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.1 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.1 | |||||
| 3-Year EBITDA Growth Rate | 1.9 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year FCF Growth Rate | -4.9 | |||||
| 3-Year Book Growth Rate | -20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.49 | |||||
| 9-Day RSI | 51.81 | |||||
| 14-Day RSI | 45.4 | |||||
| 6-1 Month Momentum % | -14.29 | |||||
| 12-1 Month Momentum % | -10 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.49 | |||||
| Quick Ratio | 8.49 | |||||
| Cash Ratio | 6.39 | |||||
| Days Sales Outstanding | 307.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 | |||||
| Shareholder Yield % | -24.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -500.64 | |||||
| Net Margin % | -386.68 | |||||
| FCF Margin % | -443.02 | |||||
| ROE % | -74.48 | |||||
| ROA % | -64.02 | |||||
| ROIC % | -502.79 | |||||
| ROC (Joel Greenblatt) % | -3067.87 | |||||
| ROCE % | -95.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.34 | |||||
| PB Ratio | 3.07 | |||||
| Price-to-Tangible-Book | 4.3 | |||||
| EV-to-EBIT | -1.68 | |||||
| EV-to-EBITDA | -1.7 | |||||
| EV-to-Revenue | 8.42 | |||||
| EV-to-FCF | -2.12 | |||||
| Price-to-Net-Current-Asset-Value | 4.3 | |||||
| Price-to-Net-Cash | 4.3 | |||||
| Earnings Yield (Greenblatt) % | -59.64 | |||||
| FCF Yield % | -37.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Gene Technology Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.623 | ||
| EPS (TTM) (A$) | -0.013 | ||
| Beta | 1.57 | ||
| Volatility % | 87.74 | ||
| 14-Day RSI | 45.4 | ||
| 14-Day ATR (A$) | 0.001757 | ||
| 20-Day SMA (A$) | 0.0452 | ||
| 12-1 Month Momentum % | -10 | ||
| 52-Week Range (A$) | 0.036 - 0.085 | ||
| Shares Outstanding (Mil) | 201.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Gene Technology Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Gene Technology Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio-Gene Technology Ltd Frequently Asked Questions
What is Bio-Gene Technology Ltd(ASX:BGT)'s stock price today?
The current price of ASX:BGT is A$0.04. The 52 week high of ASX:BGT is A$0.09 and 52 week low is A$0.04.
When is next earnings date of Bio-Gene Technology Ltd(ASX:BGT)?
The next earnings date of Bio-Gene Technology Ltd(ASX:BGT) is .
Does Bio-Gene Technology Ltd(ASX:BGT) pay dividends? If so, how much?
Bio-Gene Technology Ltd(ASX:BGT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers